Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

SB-207499: a second-generation PDE IV inhibitor from SmithKline Beecham

Oct. 8, 1997

Leukotriene antagonists useful for asthma claimed by Bayer

Oct. 7, 1997

Fujisawa prepares novel antileukotriene agents

Oct. 7, 1997

Nasonex Nasal Spray cleared for marketing in U.S.

Oct. 6, 1997

FDA clears Serevent Diskus

Oct. 3, 1997

Schering AG prepares new rolipram derivatives

Oct. 2, 1997

Dyax issued U.S. patent for novel elastase inhibitors

Oct. 2, 1997

Antileukotriene effects described for ebastine

Oct. 1, 1997

Peptidoleukotrienes and TxA2 both implicated in cough variant asthma

Oct. 1, 1997

Protective effects of Bayer's LTD4 antagonist demonstrated in asthmatic subjects

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...